Crossmark

Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study

Crossref DOI link: https://doi.org/10.1007/s10067-024-07118-9

Published Online: 2024-08-25

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rabia, Koc Emine https://orcid.org/0000-0002-0264-7284
Gizem, Güllü https://orcid.org/0000-0001-9477-5031
Furkan, Saridas https://orcid.org/0000-0001-5945-2317
Sanja, Gluscevic https://orcid.org/0000-0002-9230-9093
Nihan, Coskun Belkıs https://orcid.org/0000-0003-0298-4157
Yavuz, Pehlivan https://orcid.org/0000-0002-1201-8836
Zehra, Calikusu Fatma https://orcid.org/0000-0002-6644-6553
Faruk, Turan Omer https://orcid.org/0000-0002-6752-1519
License Information

Text and Data Mining valid from 2024-08-25

Version of Record valid from 2024-08-25
More Information

Article History

Received: 26 June 2024

Revised: 28 July 2024

Accepted: 19 August 2024

First Online: 25 August 2024

Compliance with ethical standard

:

: None.

: Our study received ethical approval from our university ethics committee.